Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sundström

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Neurology|November 22, 2012
Vitamin D as a protective factor in multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of SwedenAnne Wickström, Peter Sundström, Lucas Wickström, et al.
Annals of Neurology|August 10, 2010
Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control studyPeter Sundström, Anders Wåhlin, Khalid Ambarki, et al.
Ideggyogyaszati Szemle|May 8, 2018
How to minimize the risk for headache? A lumbar puncture practice questionnaire studyJonatan Salzer, Cecilia Rajda, Peter Sundström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Clinical Neurology and Neurosurgery|March 29, 2024
Prevalence and disease disability in immigrants with multiple sclerosis in Malmö, southern SwedenLucía Alonso-Magdalena, Olga Carmona I Codina, Elisabet Zia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2016
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosisAnne Wickström, Maria Fagerström, Lucas Wickström, et al.
Multiple Sclerosis International|March 29, 2022
Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern SwedenLucía Alonso-Magdalena, Elisabet Zia, Olga Carmona I Codina, et al.
Frontiers in Immunology|August 14, 2023
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruptionRemigius Gröning, Andy Dernstedt, Clas Ahlm, et al.
Plos One|February 9, 2018
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controlsPierre de Flon, Lars Söderström, Katarina Laurell, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Neurology|November 22, 2012
Vitamin D as a protective factor in multiple sclerosisJonatan Salzer, Göran Hallmans, Maria Nyström, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of SwedenAnne Wickström, Peter Sundström, Lucas Wickström, et al.
Annals of Neurology|August 10, 2010
Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control studyPeter Sundström, Anders Wåhlin, Khalid Ambarki, et al.
Ideggyogyaszati Szemle|May 8, 2018
How to minimize the risk for headache? A lumbar puncture practice questionnaire studyJonatan Salzer, Cecilia Rajda, Peter Sundström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Clinical Neurology and Neurosurgery|March 29, 2024
Prevalence and disease disability in immigrants with multiple sclerosis in Malmö, southern SwedenLucía Alonso-Magdalena, Olga Carmona I Codina, Elisabet Zia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2016
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosisAnne Wickström, Maria Fagerström, Lucas Wickström, et al.
Multiple Sclerosis International|March 29, 2022
Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern SwedenLucía Alonso-Magdalena, Elisabet Zia, Olga Carmona I Codina, et al.
Frontiers in Immunology|August 14, 2023
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruptionRemigius Gröning, Andy Dernstedt, Clas Ahlm, et al.
Plos One|February 9, 2018
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controlsPierre de Flon, Lars Söderström, Katarina Laurell, et al.
Pageof 6